Search Results - "ZIMBROFF, D. L"

Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia by ZIMBROFF, D. L, KANE, J. M, TAMMINGA, C. A, DANIEL, D. G, MACK, R. J, WOZNIAK, P. J, SEBREE, T. B, WALLIN, B. A, KASHKIN, K. B

“…This multicenter, double-blind, placebo-controlled study evaluated the efficacy and safety of three doses of sertindole (12, 20, and 24 mg/day) and haloperidol…”
Get full text

Placebo response in antidepressant trials by Zimbroff, D L

“…The demand by regulatory authorities for placebo-controlled trials in the evaluation of antidepressant therapies is supported by data published by Paul Leber,…”
Get full text

Patient and rater education of expectations in clinical trials (PREECT) by Zimbroff, D L

Get full text

Efficacy and safety of Aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder by KANE, John M, CARSON, William H, SAHA, Anutosh R, MCQUADE, Robert D, INGENITO, Gary G, ZIMBROFF, Dan L, ALI, Mirza W

“…Aripiprazole is an investigational agent for treating schizophrenia that has a novel pharmacologic profile. The present study investigated the efficacy,…”
Get full text

Ziprasidone 80 mg/day and 160 mg/day in the Acute Exacerbation of Schizophrenia and Schizoaffective Disorder: A 6-Week Placebo-Controlled Trial by Daniel, David G, Zimbroff, Dan L, Potkin, Steven G, Reeves, Karen R, Harrigan, Edmund P, Lakshminarayanan, Mani

“…In this double-blind study, patients with an acute exacerbation of schizophrenia or schizoaffective disorder were randomized to receive either ziprasidone 80…”
Get full text

Switching patients from clozapine to risperidone therapy by Zimbroff, D L

Get more information

Pregabalin in Generalized Anxiety Disorder: A Placebo-Controlled Trial by Pande, Atul C., Crockatt, Jerri G., Feltner, Douglas E., Janney, Carol A., Smith, Ward T., Weisler, Richard, Londborg, Peter D., Bielski, Robert J., Zimbroff, Dan L., Davidson, Jonathan R.T., Liu-Dumaw, Maria

“…OBJECTIVE: Current drug therapies for generalized anxiety disorder have limitations. In a controlled trial, the novel agent pregabalin was studied for the…”
Get full text

Pregabalin for Treatment of Generalized Anxiety Disorder: A 4-Week, Multicenter, Double-blind, Placebo-Controlled Trial of Pregabalin and Alprazolam by Rickels, Karl, Pollack, Mark H, Feltner, Douglas E, Lydiard, R. Bruce, Zimbroff, Daniel L, Bielski, Robert J, Tobias, Kathy, Brock, Jerri D, Zornberg, Gwen L, Pande, Atul C

“…BACKGROUND Pregabalin inhibits release of excess excitatory neurotransmitters, presumably by binding to the α2-δ subunit protein of widely distributed…”
Get full text

Selegiline transdermal system for the treatment of major depressive disorder : An 8-week, double-blind, placebo-controlled, flexible-dose titration trial by FEIGER, Alan D, RICKELS, Karl, RYNN, Moira A, ZIMBROFF, Dan L, ROBINSON, Donald S

“…This study investigated the efficacy, safety, and tolerability of the selegiline transdermal system (STS) administered in a dose range of 6 mg/24 hours to 12…”
Get full text

Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group by Daniel, D G, Zimbroff, D L, Potkin, S G, Reeves, K R, Harrigan, E P, Lakshminarayanan, M

“…In this double-blind study, patients with an acute exacerbation of schizophrenia or schizoaffective disorder were randomized to receive either ziprasidone 80…”
Get full text

Management of acute psychosis: from emergency to stabilization by Zimbroff, Dan L

“…In treating and managing acute psychosis in patients with schizophrenia, early intervention may be valuable. The need to quickly control severe symptoms,…”
Get more information

The tolerability of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy by Daniel, David G, Zimbroff, Dan L, Swift, Rachel H, Harrigan, Edmund P

“…The intramuscular (i.m.) formulation of ziprasidone offers promise as an alternative to conventional i.m. agents for the short-term management of agitated…”
Get full text

APA Practice Guideline for Schizophrenia: Risperidone Equivalents by REMINGTON, GARY, KAPUR, SHITIJ, ZIPURSKY, ROBERT

Get full text

Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group by Zimbroff, D L, Kane, J M, Tamminga, C A, Daniel, D G, Mack, R J, Wozniak, P J, Sebree, T B, Wallin, B A, Kashkin, K B

“…OBJECTIVE: This multicenter, double-blind, placebo-controlled study evaluated the efficacy and safety of three doses of sertindole (12, 20, and 24 mg/day) and…”
Get full text

Sertindole versus haloperidol for schizophrenia / Dr. Zimbroff and colleagues reply by Balon, Richard, Mattes, Jeffrey A, Zimbroff, Dan L, Kane, John M, Tamminga, Carol A

Get full text